range of oxygenation indices. This would result in earlier institution of HFO in some patients, using HFO to protect the lung rather than as salvage therapy. Indeed Patient 1 in our report who had the longest period of conventional ventilation pre-HFO (50 h) was treated for twice as long as the other two patients, whilst a signi®cant discriminating feature between the survivors and non-survivors in both Fort and colleagues 4 and Mehta and colleagues 5 studies was the duration of conventional ventilation before HFO. Furthermore, we used the prone position for all our patients.
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Results. The presence of helium in the carrier gas had negligible effects on the output from both of the sevo¯urane vaporizers tested. Carrier gas¯ow rates had the greatest effect on output but changes were within T10% of baseline. Conclusion. Helium/oxygen mixtures can be used with these vaporizers without adversely affecting their performance. Most modern vaporizers cope well with variations in temperature and¯ow rates within normal working ranges. The output from anaesthetic vaporizers is affected by the physical characteristics of the carrier gas. Nitrous oxide, for example, is known to produce clinically signi®cant changes at the extremes of¯ow rates and dial settings. 1 Helium is a useful adjunct in upper airway obstruction because of its low density, which reduces turbulent¯ow. 2 3 Inhalation induction of anaesthesia with sevo¯urane is an accepted technique in the management of actual or potential upper airway obstruction. 5 If inhalation induction of anaesthesia for the treatment of upper airway obstruction using a sevo¯urane and helium/oxygen combination is planned, it is important to know if the output from the vaporizer is affected by the addition of helium to the carrier gas.
Methods and results
Two models of sevo¯urane vaporizers were studied: Blease Datum â and Drager Vapor â 19.3. For each vaporizer, the effects of increasing helium concentrations, carrier gas¯ow rates and varying the vaporizer dial setting on the sevo¯urane vaporizer output was investigated using a 4Q4Q4 factorial design based on a previous vaporizer output study by RG Loeb. 4 A standard anaesthetic machine (Cavendish 460) was used to deliver the fresh gas¯ow of oxygen metered through a bobbin¯ow meter. Helium was provided from a cylinder of medical quality helium and added to the circuit via a T piece connection 30 cm proximal to the vaporizer inlet to allow for adequate mixing of gases before entering the vaporizer chambers.
A Datex Ultima â Gas Monitor was used to measure sevo¯urane concentrations 50 cm downstream from the vaporizer outlet. This was calibrated according to the manufacturer's speci®cations before each series of readings. The manufacturer quotes an anaesthetic agent identi®cation accuracy of 0.2 vol%.
Helium¯ow was calibrated using the same Datex Ultima â Gas Monitor (oxygen analysis function) by balancing the relative¯ow rates of oxygen and helium against the desired helium concentration. Helium concentrations were calculated as 100 minus measured oxygen concentration. 4 The vaporizers were drained and¯ushed to remove any possible contaminants and re®lled with fresh liquid sevo¯urane.
Measurements were taken at dial settings of 2, 4, 6, and 8% sevo¯urane from both the Blease Datum â and Drager Vapor â 19.3 vaporizers. Helium concentrations of 0, 25, 50, and 75% were studied at carrier gas¯ow rates of 1.5, 3, 6, and 12 litre min ±1 . Measurements were made in a random fashion so that temperature effects would be distributed over all the measurements. Each measurement was made after a period of 30 s of stable vaporizer output.
The data were analysed using the SPSS statistical package. Stepwise multiple linear regression analysis was used to investigate the effects of helium, carrier gas¯ow rate, dial setting, and vaporizer model on sevo¯urane output. A P value of <0.01 was accepted as signi®cant.
The multiple linear regression model explained 98.9% of the variation in output (the coef®cient of determination R 2 =98.9%, P<0.001). On further analysis, the dial setting explained 97.9% of output variation whereas the effects of increasing helium concentrations, carrier gas¯ow rates and machine type accounted for just 1% (helium concentration R 2 =0.01;¯ow rates R 2 =0.08; machine type R 2 =0.01).
To allow graphical comparative analysis (Fig. 1) , the measured sevo¯urane output concentration was converted to a percentage deviation from baseline. An increase in helium concentration resulted in a minor increase in sevo¯urane output. All changes were minimal and while statistically signi®cant on regression analysis (P<0.005) were within T10% of baseline output. The¯ow rate of the carrier gas had the greatest effect on output. Increasing the¯ow rate reduced the output of sevo¯urane from both the Blease 
Comments
The combination of sevo¯urane with helium plus oxygen mixture as carrier gas is clinically useful in anaesthesia for the management of upper airway obstruction. During inhalation induction of anaesthesia it is important to be able to rely on the vaporizer dial settings rather than on volatile agent monitors which are not always available. The aim of this study was to determine if the presence of helium in the carrier gas affects the output from two modern sevo¯urane vaporizersÐthe Blease Datum â and Drager Vapor 19.3 â .
Carvalho and Sanders
Vaporizer output is modulated by the ratio of carrier gas ow bypassing the vaporizing chamber to that which is diverted into the vaporizing chamber. Differences in density and viscosity of the carrier gases may affect the bypass splitting characteristics and ®nal performance. Helium has a low density and high critical velocity. We would expect less turbulent¯ow and generated resistance in the channels and less impact on vaporizer output. Sevo¯urane has a low saturated vapour pressure of 21.3 kPa at 20°C and, therefore, requires greater¯ow through the vaporizing chamber compared with other volatile agent vaporizers, e.g. iso¯urane. This characteristic makes sevo¯urane vaporizers more sensitive to high¯ow rate inaccuracies. The low MAC requires higher dial settings, which also impacts on the splitting ratio characteristics.
Of the variables measured, helium concentration had the least effect on output from either of the vaporizers. An increase in helium concentration did, however, result in a small increase in sevo¯urane output. All changes were minimal and while statistically signi®cant on regression analysis (P<0.005), were well within T10% of baseline output. Similar minimal effects of helium on vaporizer output have been reported for iso¯urane and en¯urane vaporizers. 1 4 Increasing the dial setting resulted in a statistically signi®cant increase in output above the expected dial value. Conversely increasing the¯ow rate of the carrier gas reduced the output of sevo¯urane from both the Blease Datum â and Drager Vapor 19.3 â vaporizers. This phenomenon is most noticeable at very high¯ow rates. These changes cannot be extrapolated to all vaporizers as different designs and calibrations impact on performance. 1 Reductions in output have been reported in a Sevotec 5 â vaporizer at high¯ows in association with a low ®ll state and a high (8%) dial setting. 6 In conclusion, increasing helium concentrations and dial settings increased output while increasing¯ow rates decreased output in both vaporizers, but variations in output delivery were all within the manufacturers' quoted accuracy and not clinically signi®cant. The clinician can be reassured that helium/oxygen mixtures can be used in conjunction with the Drager Vapor 19.3 â and Blease Datum â sevo¯urane vaporizers without adversely affecting either vaporizer's performance. Sevo¯urane vaporizers output in the presence of helium
